Nephrology Division, Hospital do Rim e Hipertensão, Universidade Federal de São Paulo, São Paulo, Brazil.
Transplantation. 2013 Feb 27;95(4):611-6. doi: 10.1097/TP.0b013e318279153c.
The discard rate of kidneys recovered from deceased donors with acute renal failure (ARF) is higher compared with those without ARF mainly due to the uncertainty regarding short-term and long-term outcomes.
We retrospectively analyzed 1-year patient, graft, and rejection-free survivals and renal function of transplantations performed with kidneys recovered from deceased donors with or without ARF, defined as serum creatinine level of more than 1.5 mg/dL. We performed multivariable analysis to evaluate whether ARF was an independent risk factor associated with inferior outcomes.
Of a total of 1518 patients, 253 received kidneys from expanded-criteria donors (ECD; with ARF [n=116] and without ARF [n=137]) and 1265 from standard-criteria donors (SCD; with ARF [n=369] and without ARF [n=896]). The incidence of delayed graft function was higher in ECD (68.1% vs. 58.4%; P=0.072) and SCD (69.9% vs. 50.6%; P<0.001) recipients of kidneys with ARF compared with those without ARF, respectively. At 1 year, patient, graft, and rejection-free survivals were not statistically different in SCD or ECD recipients with or without ARF. Renal function at 1 year was similar in recipients of ECD (41.9±26.3 vs. 40.1±21.7 mL/min; P=0.565) or SCD (50.9±29.9 vs. 53.6±28.5 mL/min; P=0.131) kidneys with and without ARF, respectively. Compared with kidneys without ARF, receiving a kidney allograft with ARF was not associated with increased risk of death, graft lost, or inferior renal function 1 year after transplantation.
In this cohort of patients, kidneys from deceased donors with ARF provided graft survival and renal function comparable with kidneys from donors without ARF 1 year after transplantation.
与无急性肾损伤 (ARF) 的供体相比,来自患有 ARF 的已故供体的肾脏的废弃率更高,主要是因为对短期和长期结果存在不确定性。
我们回顾性分析了接受来自患有或不患有 ARF 的已故供体的肾脏移植的患者、移植物和无排斥存活 1 年的情况以及肾功能,ARF 的定义为血清肌酐水平高于 1.5mg/dL。我们进行了多变量分析,以评估 ARF 是否是与不良结果相关的独立危险因素。
在总共 1518 名患者中,253 名患者接受了扩展标准供体 (ECD;ARF [n=116] 和无 ARF [n=137]) 的肾脏,1265 名患者接受了标准标准供体 (SCD;ARF [n=369] 和无 ARF [n=896]) 的肾脏。患有 ARF 的 ECD(68.1%比 58.4%;P=0.072)和 SCD(69.9%比 50.6%;P<0.001)患者的延迟移植物功能发生率分别高于无 ARF 的患者。在 SCD 或 ECD 患者中,1 年内,患有或不患有 ARF 的患者、移植物和无排斥存活均无统计学差异。1 年后,患有或不患有 ARF 的 ECD(41.9±26.3 比 40.1±21.7 mL/min;P=0.565)或 SCD(50.9±29.9 比 53.6±28.5 mL/min;P=0.131)患者的肾功能相似。与无 ARF 的肾脏相比,1 年后接受 ARF 供体的肾脏同种异体移植并未增加死亡、移植物丢失或肾功能下降的风险。
在本队列患者中,来自患有 ARF 的已故供体的肾脏在移植后 1 年提供的移植物存活率和肾功能与来自无 ARF 供体的肾脏相当。